• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Skinovation Pharm

Skinovation Pharm

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  6. Research
  1. Castanea Partners Announces Investment in First Aid Beauty®

    Castanea Partners Announces Investment in First Aid Beauty®

  2. Genzyme Strengthens Endocrinology Portfolio with Acquisition of Rare Disease Therapy Caprelsa® (vandetanib) from AstraZeneca

    Genzyme Strengthens Endocrinology Portfolio with Acquisition of Rare Disease Therapy Caprelsa® (vandetanib) from AstraZeneca

  3. Newly Appointed Acting CEO Outlines Immediate Plans for Novogen

    Newly Appointed Acting CEO Outlines Immediate Plans for Novogen

  4. RXi Pharmaceuticals to Webcast Second Quarter 2015 Financial Results on Wednesday, August 12, 2015

    RXi Pharmaceuticals to Webcast Second Quarter 2015 Financial Results on Wednesday, August 12, 2015

  5. UPDATE: 10 uncomfortable truths about the -2-

    UPDATE: 10 uncomfortable truths about the -2-

  6. Wal-Mart Warns Its Suppliers Over Labeling Laws

    Wal-Mart Warns Its Suppliers Over Labeling Laws

  7. Shiseido Announces Appointment of Marc Rey as President & CEO of Shiseido Americas

    Shiseido Announces Appointment of Marc Rey as President & CEO of Shiseido Americas

  8. Research and Markets: Structural Electronics 2015-2025: Applications, Technologies, Forecasts - In-Mold Electronics, Smart Skin , Structural Health Monitoring, Composite Smart Structures, Building ...

    Research and Markets: Structural Electronics 2015-2025: Applications, Technologies, Forecasts - In-Mold Electronics, Smart Skin , Structural Health Monitoring, Composite Smart Structures, Building Integrated Photovoltaics

  9. Non-Surgical Fat Melting Treatment for “Double Chin”

    Non-Surgical Fat Melting Treatment for “Double Chin”

  10. Enanta Pharmaceuticals Announces U.S. Regulatory Approval of TECHNIVIE™ (ombitasvir, paritaprevir and ritonavir) tablets

    Enanta Pharmaceuticals Announces U.S. Regulatory Approval of TECHNIVIE™ (ombitasvir, paritaprevir and ritonavir) tablets

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.